Literature DB >> 12565131

No association of mutations and mRNA expression of WFS1/wolframin with bipolar disorder in humans.

Tadafumi Kato1, Kazuya Iwamoto, Shinsuke Washizuka, Kanako Mori, Osamu Tajima, Tsuyoshi Akiyama, Shinichiro Nanko, Hiroshi Kunugi, Nobumasa Kato.   

Abstract

Association of WFS1 (wolframin) and bipolar disorder has been suggested by psychiatric manifestations in patients or non-symptomatic carriers of Wolfram disease and linkage of bipolar disorder with 4p16, the locus of WFS1. Five studies of WFS1 in bipolar disorder did not support this association, although possible association of several missense mutations has not been excluded yet. In this study, four such mutations were genotyped in 184 patients with bipolar disorder and 207 controls. None had the A559T and A602V mutations, and no association of G576S and H611R with bipolar disorder was found. We also quantified the expression levels of WFS1 mRNA in the postmortem brains of patients with bipolar disorder, depression, schizophrenia, and controls. There was no significant difference of the expression levels. These results did not support the pathophysiological significance of WFS1 in bipolar disorder. Copyright 2002 Elsevier Science Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12565131     DOI: 10.1016/s0304-3940(02)01334-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders.

Authors:  M P Vawter; H Tomita; F Meng; B Bolstad; J Li; S Evans; P Choudary; M Atz; L Shao; C Neal; D M Walsh; M Burmeister; T Speed; R Myers; E G Jones; S J Watson; H Akil; W E Bunney
Journal:  Mol Psychiatry       Date:  2006-04-25       Impact factor: 15.992

2.  Common variations in 4p locus are related to male completed suicide.

Authors:  Anne Must; Sulev Kõks; Eero Vasar; Gunnar Tasa; Aavo Lang; Eduard Maron; Marika Väli
Journal:  Neuromolecular Med       Date:  2008-12-25       Impact factor: 3.843

Review 3.  Endocrine and metabolic aspects of the Wolfram syndrome.

Authors:  Georgios Boutzios; Sarantis Livadas; Evangelos Marinakis; Nicole Opie; Frangiskos Economou; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2011-08       Impact factor: 3.633

4.  Prohormone convertase 2 activity is increased in the hippocampus of Wfs1 knockout mice.

Authors:  Karin Tein; Sergo Kasvandik; Sulev Kõks; Eero Vasar; Anton Terasmaa
Journal:  Front Mol Neurosci       Date:  2015-08-25       Impact factor: 5.639

5.  Effect of chronic valproic Acid treatment on hepatic gene expression profile in wfs1 knockout mouse.

Authors:  Marite Punapart; Mall Eltermaa; Julia Oflijan; Silva Sütt; Anne Must; Sulev Kõks; Leonard C Schalkwyk; Catherine Fernandes; Eero Vasar; Ursel Soomets; Anton Terasmaa
Journal:  PPAR Res       Date:  2014-04-01       Impact factor: 4.964

6.  Mania in Wolfram's Disease: From Bedside to Bench.

Authors:  Seshadri Sekhar Chatterjee; Sayantanava Mitra; Salil Kumar Pal
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-02-28       Impact factor: 2.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.